Replimune Group Inc. (NASDAQ: REPL) stock jumped 0.61% on Monday to $18.00 against a previous-day closing price of $17.89. With 0.61 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.56 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $18.11 whereas the lowest price it dropped to was $17.46. The 52-week range on REPL shows that it touched its highest point at $29.52 and its lowest point at $15.07 during that stretch. It currently has a 1-year price target of $50.30. Beta for the stock currently stands at 1.64.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of REPL was down-trending over the past week, with a drop of -9.04%, but this was down by -5.66% over a month. Three-month performance dropped to -24.53% while six-month performance fell -8.16%. The stock gained 3.51% in the past year, while it has lost -33.82% so far this year. A look at the trailing 12-month EPS for REPL yields -2.97 with Next year EPS estimates of -3.73. For the next quarter, that number is -0.86. This implies an EPS growth rate of -32.40% for this year and -8.70% for next year.
Float and Shares Shorts:
At present, 66.37 million REPL shares are outstanding with a float of 54.37 million shares on hand for trading. On Aug 30, 2023, short shares totaled 8.17 million, which was 13.84% higher than short shares on Jul 30, 2023. In addition to REAL as the firm’s The RealReal, Inc., RELL serves as its Richardson Electronics, Ltd.
Institutional Ownership:
Other institutions hold 46.67% of REPL, in contrast to 37.59% held by mutual funds. Shares owned by individuals account for 36.23%. As the largest shareholder in REPL with 9.52% of the stake, T. Rowe Price Associates, Inc. holds 5,613,768 shares worth 5,613,768. A second-largest stockholder of REPL, Baker Bros. Advisors LP, holds 4,578,280 shares, controlling over 7.76% of the firm’s shares. Redmile Group LLC is the third largest shareholder in REPL, holding 4,420,533 shares or 7.49% stake. With a 4.14% stake in REPL, the T Rowe Price New Horizons Fund is the largest stakeholder. A total of 2,445,614 shares are owned by the mutual fund manager. The T Rowe Price Health Sciences Fund, which owns about 2.61% of REPL stock, is the second-largest Mutual Fund holder. It holds 1,540,691 shares valued at 31.46 million. Vanguard Total Stock Market ETF holds 2.40% of the stake in REPL, owning 1,418,904 shares worth 28.97 million.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Jun 29, 2023, REPL reported revenue of $0.00 and operating income of -$40.02M. The EBITDA in the recently reported quarter was -$41.42M and diluted EPS was -$0.78.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for REPL since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With REPL analysts setting a high price target of $70.00 and a low target of $33.00, the average target price over the next 12 months is $50.30. Based on these targets, REPL could surge 288.89% to reach the target high and rise by 83.33% to reach the target low. Reaching the average price target will result in a growth of 179.44% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.
Summary of Insider Activity:
Insiders traded REPL stock several times over the past three months with 5 Buys and 4 Sells. In these transactions, 40,000 shares were bought while 40,000 shares were sold. The number of buy transactions has increased to 15 while that of sell transactions has risen to 17 over the past year. The total number of shares bought during that period was 514,600 while 155,966 shares were sold.
